CA2617370C - Assimilation cellulaire amelioree d'agents bioactifs - Google Patents

Assimilation cellulaire amelioree d'agents bioactifs Download PDF

Info

Publication number
CA2617370C
CA2617370C CA2617370A CA2617370A CA2617370C CA 2617370 C CA2617370 C CA 2617370C CA 2617370 A CA2617370 A CA 2617370A CA 2617370 A CA2617370 A CA 2617370A CA 2617370 C CA2617370 C CA 2617370C
Authority
CA
Canada
Prior art keywords
glutamine
cells
composition
uptake
absorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2617370A
Other languages
English (en)
Other versions
CA2617370A1 (fr
Inventor
Edward C. Shinal
Robert G. Petit
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Inc
Original Assignee
Eisai Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Inc filed Critical Eisai Inc
Priority claimed from CA002374003A external-priority patent/CA2374003C/fr
Publication of CA2617370A1 publication Critical patent/CA2617370A1/fr
Application granted granted Critical
Publication of CA2617370C publication Critical patent/CA2617370C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2617370A 1999-05-17 2000-05-15 Assimilation cellulaire amelioree d'agents bioactifs Expired - Fee Related CA2617370C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13444299P 1999-05-17 1999-05-17
US60/134,442 1999-05-17
CA002374003A CA2374003C (fr) 1999-05-17 2000-05-15 Assimilation cellulaire amelioree d'agents bioactifs

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002374003A Division CA2374003C (fr) 1999-05-17 2000-05-15 Assimilation cellulaire amelioree d'agents bioactifs

Publications (2)

Publication Number Publication Date
CA2617370A1 CA2617370A1 (fr) 2000-11-23
CA2617370C true CA2617370C (fr) 2011-11-01

Family

ID=39277265

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2617370A Expired - Fee Related CA2617370C (fr) 1999-05-17 2000-05-15 Assimilation cellulaire amelioree d'agents bioactifs

Country Status (1)

Country Link
CA (1) CA2617370C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4087648A4 (fr) * 2019-03-12 2024-05-01 General Electric Company Neuromodulation pour cibler les voies des transporteurs de glucose et/ou des incrétines

Also Published As

Publication number Publication date
CA2617370A1 (fr) 2000-11-23

Similar Documents

Publication Publication Date Title
US6734170B2 (en) Cellular uptake of bioactive agents
US20100152130A1 (en) Treatment of cancer with glutamine
US6936589B2 (en) Parenteral delivery systems
TWI429405B (zh) 用於靜脈營養療法的小兒胺基酸溶液
ES2274299T3 (es) Estimulacion de la produccion in vivo de proteinas con una formulacion que comprende leucina.
US20130338228A1 (en) Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate
TWI397418B (zh) 抗憂鬱劑
JP2000007570A (ja) 抗内分泌障害剤
CA2617370C (fr) Assimilation cellulaire amelioree d'agents bioactifs
WO2005110046A2 (fr) Methode visant a accroitre l'apport du facteur de croissance des keratinocytes
JP2005350371A (ja) 肝障害者用栄養組成物
US20240365834A1 (en) Dietary supplement compositions and methods for their use in post-workout recovery
JP3275183B2 (ja) 輸液剤とその製造方法
Maccario et al. L-arginine

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20190515